Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
Frontiers in Immunology|August 21, 2019
On the Way to Become a Natural Killer CellClara Di Vito, Joanna Mikulak, Domenico MavilioMediators of Inflammation|February 17, 2016
Fostering Inflammatory Bowel Disease: Sphingolipid Strategies to Join ForcesLoubna Abdel Hadi, Clara Di Vito, Laura RiboniFrontiers in Immunology|December 19, 2019
Innate Immune Responses in the Outcome of Haploidentical Hematopoietic Stem Cell Transplantation to Cure Hematologic MalignanciesElisa Zaghi, Michela Calvi, Clara Di Vito, et al.Frontiers in Immunology|April 8, 2017
Host Immune Responses in HIV-1 Infection: The Emerging Pathogenic Role of Siglecs and Their Clinical CorrelatesJoanna Mikulak, Clara Di Vito, Elisa Zaghi, et al.Journal of Leukocyte Biology|January 16, 2019
Targeting NKG2A to elucidate natural killer cell ontogenesis and to develop novel immune-therapeutic strategies in cancer therapyElisa Zaghi, Michela Calvi, Emanuela Marcenaro, et al.AIDS (London, England)|September 20, 2017
Natural killer cells in HIV-1 infection and therapyJoanna Mikulak, Ferdinando Oriolo, Elisa Zaghi, et al.Frontiers in Immunology|May 23, 2019
Hepatic Natural Killer Cells: Organ-Specific Sentinels of Liver Immune Homeostasis and PhysiopathologyJoanna Mikulak, Elena Bruni, Ferdinando Oriolo, et al.Seminars in Immunology|May 16, 2019
NK cells to cure cancerClara Di Vito, Joanna Mikulak, Elisa Zaghi, et al.Biochimica Et Biophysica Acta|July 7, 2012
The phytoestrogen 8-prenylnaringenin inhibits agonist-dependent activation of human plateletsClara Di Vito, Alessandra Bertoni, Michela Nalin, et al.Frontiers in Immunology|June 20, 2022
Development of Human ILCs and Impact of Unconventional Cytotoxic Subsets in the Pathophysiology of Inflammatory Diseases and CancerMichela Calvi, Clara Di Vito, Alessandro Frigo, et al.Pageof 5